iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5
iCAD, a leader in cancer detection and therapy solutions, announced it will release its financial results for Q2 and six-months ending June 30, 2021, on August 5, 2021, after market close. This will be followed by a conference call at 4:30 PM ET. The call aims to discuss performance metrics, offering insights into the company’s financial health and strategic direction. Investors are encouraged to join the call to gain a comprehensive understanding of iCAD's progress and outlook.
- Scheduled conference call for Q2 results indicates transparency and investor engagement.
- None.
NASHUA, N.H., July 22, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter and six-months ended June 30, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Thursday, August 5.
Thursday, August 5th @ 4:30pm ET | |
Domestic: | 888-254-3590 |
International: | 323-994-2082 |
Conference ID: | 6177004 |
Webcast: | http://public.viavid.com/index.php?id=145901 |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com
FAQ
When will iCAD release its financial results for Q2 2021?
What time is the iCAD conference call to discuss Q2 results?